RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm, founded in 2021 by CEO Mesfin Tegenu, is built on nearly 30 years of industry expertise, delivering innovative pharmacy

Read More »

Expert Tip from PharmaForce

img
img

TIP: Maintain an accurate and comprehensive provider list to maximize 340B program effectiveness and compliance.


An outdated

Read More »

J&J’s 340B Rebate Vendor to Host In-Person Training Next Monday Despite Government’s Objection to Proposal

Beacon Channel Management is holding multiple trainings on its 340B rebate platform.
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

Bayer wordmark on side of building
Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Relents on Arkansas Contract Pharmacy Law; AbbVie Exempts MO, MS Covered Entities

Johnson & Johnson building-mounted sign
Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

UPDATED: Certain NDCs for Four of Ten Newly Announced Medicare Negotiated Drug Prices Are Below Current 340B Prices

CMS announced the "maximum fair price" for the first ten drugs selected for Medicare drug price negotiations.
Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

EMD Serono Extends 340B Contract Pharmacy Restrictions to All Covered Entities & Adds New Restrictions

EMD Serono wordmark on building
Beginning Oct. 1, EMD Serono will extend its contract pharmacy restrictions to all 340B covered entities.
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal

Two major hospital groups urged the government to take enforcement action against J&J's 340B rebate proposal.
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Analysis Finds Growing Private Equity, Corporate Investments in 340B; Firm Conducting Study Fails to Mention Its Own PE Funding

A new Berkeley Research Group issue brief looked at trends in 340B investments.
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Preparing for a Neutral 340B Claims Clearinghouse

SPONSORED CONTENT

On June 18th, RxParadigm hosted a webinar to discuss the pressing need for a 340B clearinghouse. Legislative changes at both state and federal levels for the 340B program could be imminent, requiring all stakeholders to adapt to new standards

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live